Diagnostic value of maternal serum prokineticin-1 for predicting placenta accreta spectrum and adverse maternal outcomes
Zeitschrift für Geburtshilfe und Neonatologie · 02.11.2026
DOI: 10.1055/a-2917-2141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Geburtshilfe und Neonatologie, online erschienen am 02.11.2026. Verfasst von Süleyman Cemil Oğlak und 10 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences University, Gazi Yaşargil Training and Research Hospital, Department of Obstetrics and Gynecology, Turkey, Diyarbakır. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
This study aimed to evaluate maternal serum prokineticin-1 (PROK1) levels in women with placenta accreta spectrum (PAS) of varying degrees, to compare them with cases of placenta previa (PP) and uncomplicated healthy pregnancies, and to determine whether this biomarker can predict disease severity and clinical outcomes. In this observational case-control study involving 153 pregnant women, 54 had singleton pregnancies with PP complicated by PAS, 51 had PP without PAS, and 48 were healthy gestational age-matched singleton controls. Demographic and clinical data, maternal and neonatal outcomes, and maternal serum PROK1 levels were collected for all participants. A receiver operating characteristic (ROC) curve was generated to assess the sensitivity and specificity of PROK1, and the optimal cut-off value was determined using the Youden index. Associations between PROK1 levels and continuous clinical variables were analyzed using Spearman’s rank correlation. The mean maternal serum PROK1 level was markedly elevated in both the PAS group (9.29±10.53 pg/mL) and the PP group (6.65±2.88 pg/mL) compared with the control group (3.19±0.81 pg/mL, p
Autor:innen und Institutionen
- Health Sciences University, Gazi Yaşargil Training and Research Hospital, Department of Obstetrics and Gynecology, Turkey, Diyarbakır.
- Acıbadem Hospitals Group, Department of Obstetrics and Gynecology, Turkey, Istanbul.
ORCID-Profile: Süleyman Cemil Oğlak, Fatma Ölmez, İhsan Bağlı, Mesut Ali Halisçelik, Abdullah Acar, Emine Acar, Fuat Bozan, Özgür Adıgüzel, Hümeyra Elif Ateş Eminoğlu, Havva Güleli, Sedat Akgöl
Zitieren
APA
Oğlak, S. C., Ölmez, F., Bağlı, İ., Halisçelik, M. A., Acar, A., Acar, E., Bozan, F., Adıgüzel, Ö., Ateş Eminoğlu, H. E., Güleli, H., & Akgöl, S. (2026). Diagnostic value of maternal serum prokineticin-1 for predicting placenta accreta spectrum and adverse maternal outcomes. Zeitschrift für Geburtshilfe und Neonatologie. https://doi.org/10.1055/a-2917-2141
Vancouver
Oğlak SC, Ölmez F, Bağlı İ, Halisçelik MA, Acar A, Acar E, et al. Diagnostic value of maternal serum prokineticin-1 for predicting placenta accreta spectrum and adverse maternal outcomes. Zeitschrift für Geburtshilfe und Neonatologie. 2026. doi:10.1055/a-2917-2141
BibTeX
@article{Olak2026,
author = {Oğlak, Süleyman Cemil and Ölmez, Fatma and Bağlı, İhsan and Halisçelik, Mesut Ali and Acar, Abdullah and Acar, Emine and Bozan, Fuat and Adıgüzel, Özgür and Ateş Eminoğlu, Hümeyra Elif and Güleli, Havva and Akgöl, Sedat},
title = {Diagnostic value of maternal serum prokineticin-1 for predicting placenta accreta spectrum and adverse maternal outcomes},
journal = {Zeitschrift für Geburtshilfe und Neonatologie},
year = {2026},
doi = {10.1055/a-2917-2141}
}
EUVIMED